ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB – Get Free Report) saw a large decline in short interest in the month of December. As of December 15th, there was short interest totalling 3,900 shares, a decline of 7.1% from the November 30th total of 4,200 shares. Based on an average daily volume of 12,300 shares, the days-to-cover ratio is currently 0.3 days.
Hedge Funds Weigh In On ProShares Ultra Nasdaq Biotechnology
An institutional investor recently raised its position in ProShares Ultra Nasdaq Biotechnology stock. Jane Street Group LLC increased its holdings in ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB – Free Report) by 8.4% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 4,803 shares of the exchange traded fund’s stock after buying an additional 374 shares during the period. Jane Street Group LLC owned 0.35% of ProShares Ultra Nasdaq Biotechnology worth $306,000 as of its most recent SEC filing.
ProShares Ultra Nasdaq Biotechnology Stock Up 0.9 %
Shares of NASDAQ BIB traded up $0.43 during trading on Wednesday, reaching $50.66. 5,849 shares of the stock traded hands, compared to its average volume of 22,066. ProShares Ultra Nasdaq Biotechnology has a 52-week low of $47.19 and a 52-week high of $69.56. The company has a 50-day moving average of $57.66 and a 200-day moving average of $61.55.
ProShares Ultra Nasdaq Biotechnology Increases Dividend
About ProShares Ultra Nasdaq Biotechnology
ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period.
Read More
- Five stocks we like better than ProShares Ultra Nasdaq Biotechnology
- How to Capture the Benefits of Dividend Increases
- Work and Play: Investing in the Rise of Bleisure Travel
- What is a support level?
- Top Dividend Stocks to Buy Now as Bond Yields Could Lower
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- SAP: AI Tailwinds Accelerating Enterprise Cloud Business
Receive News & Ratings for ProShares Ultra Nasdaq Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares Ultra Nasdaq Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.